Circulation January 2003 PMID 12551878

Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association.

Thomas A Pearson, George A Mensah, R Wayne Alexander, Jeffrey L Anderson, Richard O Cannon, Michael Criqui, Yazid Y Fadl, Stephen P Fortmann, Yuling Hong, Gary L Myers, Nader Rifai, Sidney C Smith, Kathryn Taubert, Russell P Tracy, Frank Vinicor

Mentions

4
Peak: 2 in Mar 2023
across 2 sources since Mar 2023

Extended reach

16,767
potential audience

Total likes

5

Video views

716

Mentions per month

Mar 2023 – Dec 2025

Where it's discussed

  • X / Twitter2 posts
  • YouTube2 videos

AI synopsis

What people are saying

We're still gathering social media discussions on this article. A synopsis appears once there are enough posts to summarize.

AgreementNeither agree nor disagree
InterestNeutral interest
EngagementNeutral engagement
ImpactNeutral impact

Abstract in brief

  • This document discusses how markers of inflammation, such as certain proteins in the blood, can be used to identify and assess the risk of cardiovascular disease in patients.
  • It emphasizes the importance of incorporating these markers into clinical practice to help with early diagnosis, prevention, and management of heart-related conditions.
  • The statement also highlights the role of public health initiatives in using inflammation markers to improve overall cardiovascular health outcomes in communities.]

Top posts

Most liked on X and Bluesky
Javi Ciborro
@papayaykware · X

https://t.co/LFAAOLTr6e

Mar 13, 2023 · 8,026 followers View post →
Javi Ciborro
@papayaykware · X

https://t.co/yvdUh396cj

Mar 16, 2023 · 8,026 followers View post →

All mentions

Javi Ciborro
@papayaykware · X

https://t.co/yvdUh396cj

Mar 16, 2023 · 8,026 followers View post →
Javi Ciborro
@papayaykware · X

https://t.co/LFAAOLTr6e

Mar 13, 2023 · 8,026 followers View post →